Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BCYC - Bicycle Therapeutics GAAP EPS of -$0.93 misses by $0.26 revenue of $3.86M misses by $0.55M

BCYC - Bicycle Therapeutics GAAP EPS of -$0.93 misses by $0.26 revenue of $3.86M misses by $0.55M

Bicycle Therapeutics plc
Bicycle Therapeutics press release (NASDAQ:BCYC): Q1 GAAP EPS of -$0.93 misses by $0.26. Revenue of $3.86M (+113.3% Y/Y) misses by $0.55M. CEO comment: “Beyond our Bicycle Toxin Conjugates®, or BTCs, we continue to be encouraged as we progress our Bicycle TICA™ programs forward, including BT7480, which is advancing in the dose escalation portion of the Phase I clinical trial. Underscoring our efforts is a strong balance sheet and we anticipate our cash and cash equivalents will provide financial runway through 2024.”

For further details see:

Bicycle Therapeutics GAAP EPS of -$0.93 misses by $0.26, revenue of $3.86M misses by $0.55M
Stock Information
Company Name: Bicycle Therapeutics plc
Stock Symbol: BCYC
Market: NYSE
Website: bicycletherapeutics.com
Menu
BCYC BCYC Quote BCYC Short BCYC News BCYC Articles BCYC Message Board
Get BCYC Alerts

News, Short Squeeze, Breakout and More Instantly...